| KONNANCE MINERVA NEUROSCIENCES INC.
1981973 23 Aug 2019 | on 06 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions, namely, Alzheimer's, Huntington's Disease, cerebral palsy, myasthenia gravis, brain injury, spinal cord injury, seizure disorders, anxiety disorders, bipolar disorders, and psychoses; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations, namely, serotonin receptor and sigma receptor blockers | | | KONNANCE & DESIGN MINERVA NEUROSCIENCES INC.
2289485 26 Oct 2023 | on 04 Oct 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders, and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors. | |